Latest From Biotech Now

Patent Trolls and Patent Litigation: The GAO Weighs In

shutterstock_26191726

Patent troll litigation alarmist were likely disappointed by the GAO report.  While the public discourse may have already concluded that patent trolls have laid waste to the innovative landscape by creating a patent litigation crisis, the GAO report does not find much evidence to support such claims. Patent troll litigation is not running rampant.  The GAO analyzed a sample of 500 patent infringement lawsuits from 2007 to 2011 and found that companies that make products (operating Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Driving Innovation in Breast Cancer: Startup Challenge

Driving Innovation

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for Advancing Innovation (CAI) have partnered to launch a “first of a kind” Business Plan and Start-Up Challenge for Breast Cancer (BC) inventions that have high commercial viability and are important to public health. This challenge will accelerate the commercialization of Federal agency and AF grantee BC inventions, spur economic growth, and provide Universities a platform to further develop their entrepreneurship learning portfolio. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Call For Sessions – Speak Now. The Industry is Listening.

BIO_SESSIONS-homepage_115x76

BIO is seeking to bring the most innovative thinkers in biotechnology together at the BIO International Convention, June 23-26th, 2014, in San Diego, CA. Speaking at the BIO International Convention gives you access to biotech thought leaders from over 4,000 companies in 65 countries. BIO is seeking speakers who are forward leaning, engaging and who drive meaningful discussion about what’s on the forefront of the industry. Education enhancements in 2014 include: streamlined session tracks organized Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Company Snapshot: DLVR Therapeutics

DLVR

DLVR Therapeutics will be presenting in the Discovery Company Track at the upcoming BIO Investor Forum. Below, this early-stage company based in Ontario, answers our snapshot questions to provide attendees and readers with more perspective on their work. Company Snapshot What is your company’s lead product or technology?  DLVR is developing an innovative nanoparticle for delivery of nucleotides, such as small interfering RNA (siRNA). Our key differentiator is the synthesis of an HDL-mimetic phospholipid-based particle Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

Despite Opposition from the Scientific Community, Efforts to Label GMOs Continue

Ag Biotech: Going on the Offense

The editors of Scientific American™ have notably compiled several firm arguments to counter support for labeling of foods made from genetically modified organisms (GMOs).  In their recent editorial titled, Label for GMO Foods Are a Bad Idea, Scientific American™ has successfully demonstrated how GMO labeling limits consumer choice, how foods containing GM ingredients can provide consumers with vital nutrients and how GMOs can be less costly to their conventional counterparts.  Here is a sample of Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,